2025-04-03 - Analysis Report
## Honeywell International Inc. (HON) Stock Review

**0. Summary Statistics:**

* **Ticker:** HON
* **Company:** Honeywell International Inc. is a diversified technology and manufacturing company.
* **Cumulative Return (HON):** 54.16%
* **Cumulative Return (VOO):** 89.44%
* **Return Difference (HON vs. VOO):** -35.28%
* **Relative Underperformance:** 23.4% (based on historical range)


**1. Performance Comparison (HON vs. VOO):**

Honeywell International Inc. (HON) has underperformed the S&P 500 (VOO) significantly over the reviewed period.  While VOO achieved a cumulative return of 89.44%, HON's return was only 54.16%, resulting in a difference of -35.28%.  The relative underperformance of 23.4% indicates that this underperformance is near the lower end of the historical range of underperformance against the S&P 500.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 35.0% | 5.4% | 18.0% | -0.0 | 82.9 |
| 2016-2018  | 16.0% | 35.5% | 9.0% | 0.5 | 76.1 |
| 2017-2019  | 37.0% | 35.5% | 17.0% | 0.2 | 104.0 |
| 2018-2020  | 46.0% | 35.5% | 11.0% | 0.4 | 127.9 |
| 2019-2021  | 46.0% | 20.4% | -27.0% | 0.5 | 127.5 |
| 2020-2022  | 28.0% | 54.5% | 17.0% | 0.5 | 133.8 |
| 2021-2023  | -3.0% | 54.5% | -21.0% | 0.8 | 133.8 |
| 2022-2024  | -3.0% | 54.5% | -26.0% | 0.8 | 147.2 |
| 2023-2025  | -13.0% | 50.8% | -54.0% | 0.8 | 139.8 |

The data shows fluctuating alpha and beta values across different periods.  The negative alpha values in some years suggest underperformance relative to the market, aligning with the overall underperformance against the VOO. The increasing beta in recent years suggests higher market sensitivity.


**2. Recent Price Movement:**

* **Closing Price:** $213.45
* **Last Market Price:** $215.22
* **5-Day Moving Average:** $212.57
* **20-Day Moving Average:** $210.85
* **60-Day Moving Average:** $213.79

The price is currently above all three moving averages, suggesting a short-term upward trend.  The recent increase of $0.83 (from $213.45 to $215.22) indicates a small, positive price movement.

**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.44 (Medium Risk)
* **RSI:** 67.89 (Approaching overbought territory)
* **PPO:** 0.23 (Positive, suggesting bullish momentum)
* **Relative Strength Change (20-day):** +4.0 (Short-term upward trend)
* **Expected Return (2+ years):** -8.3% (Expected underperformance relative to S&P 500 over the long term)

The RSI suggests the stock might be slightly overbought, while the PPO indicates positive momentum.  The positive relative strength change supports the short-term upward trend. The negative expected return highlights the continued concern about long-term underperformance compared to the S&P 500.

**4. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출         |
|------------|------|---------------|
| 2024-10-24 | 2.17 | $9.73 Billion |
| 2024-07-25 | 2.37 | $9.58 Billion |
| 2024-04-25 | 2.24 | $9.11 Billion |
| 2023-10-26 | 2.29 | $9.21 Billion |
| 2024-10-24 | 2.29 | $9.21 Billion | *(Duplicate Entry)*

Earnings show some fluctuation.  Note the duplicate entry for October 24th, 2024 which needs clarification.  A more comprehensive analysis requires consistent and accurate data.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31  | $10.09B     | 36.38%        |
| 2024-09-30  | $9.73B      | 38.54%        |
| 2024-06-30  | $9.58B      | 38.85%        |
| 2024-03-31  | $9.11B      | 38.68%        |
| 2023-12-31  | $9.44B      | 34.31%        |

Revenue shows a generally upward trend, with a slight dip in Q1 2024.  Profit margins are relatively high and consistent, except for a decrease in Q4 2023.


**Capital and Profitability:**

| Quarter     | Equity      | ROE          |
|-------------|-------------|--------------|
| 2024-12-31  | $18.62B     | 6.90%        |
| 2024-09-30  | $17.41B     | 8.12%        |
| 2024-06-30  | $16.95B     | 9.11%        |
| 2024-03-31  | $16.45B     | 8.89%        |
| 2023-12-31  | $15.86B     | 7.97%        |

Equity and ROE show a generally upward trend, indicating improving financial health.


**6. Overall Analysis:**

HON has significantly underperformed the S&P 500 over the period reviewed.  While recent price movements suggest a short-term upward trend,  long-term projections indicate continued underperformance.  Technical indicators present a mixed picture.  Fundamental analysis shows reasonably strong revenue and profitability, though further investigation into the earnings data and potential factors contributing to the underperformance is needed.  The high relative underperformance warrants caution before considering investment.  Investors should carefully weigh the potential risks before making investment decisions.  More detailed analysis, including a deeper dive into the company's specific business segments and competitive landscape, is needed for a more comprehensive assessment.
